1. Home
  2. LEGN

as 09-12-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Founded: 2014 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 6.7B IPO Year: 2020
Target Price: $73.36 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 12
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.78 EPS Growth: N/A
52 Week Low/High: $27.34 - $52.31 Next Earning Date: 11-11-2025
Revenue: $796,838,000 Revenue Growth: 74.75%
Revenue Growth (this year): 70.75% Revenue Growth (next year): 52.47%

LEGN Daily Stock ML Predictions

Share on Social Networks: